Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults
NCT03392389
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
124
Enrollment
INDUSTRY
Sponsor class
Conditions
Human Metapneumovirus and Human Parainfluenza Infection
Interventions
BIOLOGICAL:
mRNA-1653
OTHER:
Placebo
Sponsor
ModernaTX, Inc.